168 related articles for article (PubMed ID: 9497867)
1. Oncogenic osteomalacia: is there a new phosphate regulating hormone?
Nelson AE; Robinson BG; Mason RS
Clin Endocrinol (Oxf); 1997 Dec; 47(6):635-42. PubMed ID: 9497867
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced osteomalacia and the regulation of phosphate homeostasis.
Kumar R
Bone; 2000 Sep; 27(3):333-8. PubMed ID: 10962341
[TBL] [Abstract][Full Text] [Related]
3. [From gene to disease; hypophosphataemic rickets and the PHEX gene].
Jansen M; van Dael CM; Verrijn Stuart AA; van der Hout AH; Rump P
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1390-4. PubMed ID: 16841587
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology of hypophosphataemic rickets and oncogenic osteomalacia.
Rowe PS
Hum Genet; 1994 Nov; 94(5):457-67. PubMed ID: 7959677
[TBL] [Abstract][Full Text] [Related]
5. The molecular background to hypophosphataemic rickets.
Rowe PS
Arch Dis Child; 2000 Sep; 83(3):192-4. PubMed ID: 10952628
[No Abstract] [Full Text] [Related]
6. The role of the PHEX gene (PEX) in families with X-linked hypophosphataemic rickets.
Rowe PS
Curr Opin Nephrol Hypertens; 1998 Jul; 7(4):367-76. PubMed ID: 9690034
[TBL] [Abstract][Full Text] [Related]
7. The PEX gene: its role in X-linked rickets, osteomalacia, and bone mineral metabolism.
Rowe PS
Exp Nephrol; 1997; 5(5):355-63. PubMed ID: 9386970
[No Abstract] [Full Text] [Related]
8. The PEX gene: not a simple answer for X-linked hypophosphataemic rickets and oncogenic osteomalacia.
Nelson AE; Mason RS; Robinson BG
Mol Cell Endocrinol; 1997 Sep; 132(1-2):1-5. PubMed ID: 9324040
[No Abstract] [Full Text] [Related]
9. [Molecular aspects of familial hypophosphatemic rickets].
Sułek A
Med Wieku Rozwoj; 1999; 3(1):97-112. PubMed ID: 10910642
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
[TBL] [Abstract][Full Text] [Related]
12. What have we learnt about the regulation of phosphate metabolism?
Blumsohn A
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):397-401. PubMed ID: 15199289
[TBL] [Abstract][Full Text] [Related]
13. [Fibroblast growth factor 23, a new phosphaturic factor in hypophosphatemic rickets/osteomalacia].
Nishizawa Y; Imanishi Y
Nihon Rinsho; 2005 Oct; 63 Suppl 10():469-74. PubMed ID: 16279684
[No Abstract] [Full Text] [Related]
14. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
Quarles LD
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
[TBL] [Abstract][Full Text] [Related]
15. FGF23, hypophosphatemia, and rickets: has phosphatonin been found?
Strewler GJ
Proc Natl Acad Sci U S A; 2001 May; 98(11):5945-6. PubMed ID: 11371627
[No Abstract] [Full Text] [Related]
16. Phosphate wasting in oncogenic osteomalacia: PHEX is normal and the tumor-derived factor has unique properties.
Nelson AE; Hogan JJ; Holm IA; Robinson BG; Mason RS
Bone; 2001 Apr; 28(4):430-9. PubMed ID: 11336925
[TBL] [Abstract][Full Text] [Related]
17. Identification of fifteen novel PHEX gene mutations in Finnish patients with hypophosphatemic rickets.
Tyynismaa H; Kaitila I; Näntö-Salonen K; Ala-Houhala M; Alitalo T
Hum Mutat; 2000 Apr; 15(4):383-4. PubMed ID: 10737991
[TBL] [Abstract][Full Text] [Related]
18. A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma.
John MR; Wickert H; Zaar K; Jonsson KB; Grauer A; Ruppersberger P; Schmidt-Gayk H; Murer H; Ziegler R; Blind E
Bone; 2001 Oct; 29(4):393-402. PubMed ID: 11595624
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.
Wilkins GE; Granleese S; Hegele RG; Holden J; Anderson DW; Bondy GP
J Clin Endocrinol Metab; 1995 May; 80(5):1628-34. PubMed ID: 7745010
[TBL] [Abstract][Full Text] [Related]
20. A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets.
Econs MJ; Friedman NE; Rowe PS; Speer MC; Francis F; Strom TM; Oudet C; Smith JA; Ninomiya JT; Lee BE; Bergen H
J Clin Endocrinol Metab; 1998 Oct; 83(10):3459-62. PubMed ID: 9768646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
